Skip to main content

Liang Philip's Form 4/A amendment

Amended

Vicarious Surgical Inc. (RBOT) · filed Feb 9, 2023

Accession no.
0001213900-23-009900
Filed
Feb 9, 2023
Trade date
Feb 6, 2023
Filing delay
3 days
Rule 10b5-1 plan
Not on the form (before 2023)
Original filed
Feb 8, 2023

This filing lists 1 non-derivative transaction. Open-market purchases total $81.8K. It was filed 3 days after the trade.

This amendment replaces 0001213900-23-009493 (filed Feb 8, 2023).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Liang PhilipCIK 0001883781Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 6, 2023Class A Common StockPPurchaseAcquired+26,811$3.05F2+$81,773.5526,811Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction.

F2

This figure is the weighted average sales price of multiple trades ranging from $3.02 to $3.0609 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

Referenced by the price of 1 transaction in Table I.

F3

Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein.

F4

Shares held directly by Chelvey International Limited. E15 Fund II, LP, the sole shareholder of Chelvey International Limited, may be deemed to have sole voting and dispositive power over the shares held by Chelvey International Limited. The Reporting Person, as the managing partner of E15 Fund II, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund II, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund II, LP, except to the extent of any pecuniary interest therein.

F5

Shares held directly by E15 Fund Advisors (HK) Limited. The Reporting Person, as the managing partner of E15 Fund Advisors (HK) Limited, may be deemed to share voting and dispositive power over the shares held by E15 Fund Advisors (HK) Limited. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund Advisors (HK) Limited, except to the extent of any pecuniary interest therein.

Remarks

On February 8, 2023, the Reporting Person filed a Form 4 which inadvertently reported a transaction directly by the Reporting Person. In fact, the reported transaction was by E15 Fund III, LP, an entity affiliated with the Reporting Person, as reported in this amendment. This Form 4 amendment is intended to replace, in its entirety, the Form 4 filed on February 8, 2023.

Read the full filing on SEC EDGAR (opens in a new tab)